Stay updated on Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Ovarian cancer and the MedlinePlus Genetics related topics have been removed from the study page.
    Difference
    0.1%
    Check dated 2026-03-13T19:29:45.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. No visible study content or navigation changes are apparent.
    Difference
    0.0%
    Check dated 2026-03-06T18:20:25.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The study status updated to Recruiting on 2026-02-12, replacing Not yet recruiting; the record revision advanced from v3.4.1 to v3.4.2.
    Difference
    0.2%
    Check dated 2026-02-13T13:33:30.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.0 to v3.4.1 on the page.
    Difference
    0.0%
    Check dated 2026-02-06T09:11:09.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Replaced the 'Last Update Posted (Estimated)' label with a plain 'Last Update Posted' label on the study record. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-22T09:38:59.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and the previous v3.3.3 revision was removed.
    Difference
    0.0%
    Check dated 2026-01-15T05:07:52.000Z thumbnail image

Stay in the know with updates to Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page.